|
Mar 11
|
CytomX Therapeutics Inc (CTMX) Reports 2023 Financial Results and Provides Pipeline Update
|
|
Mar 11
|
CytomX Therapeutics (CTMX) Lags Q4 Earnings Estimates
|
|
Mar 11
|
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
|
|
Mar 4
|
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
|
|
Feb 13
|
CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) largest shareholders are retail investors with 50% ownership, institutions own 29%
|
|
Jan 15
|
Iovance (IOVA) Surges More Than 150% in 3 Months: Here's Why
|
|
Jan 15
|
Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why
|
|
Jan 12
|
Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine
|
|
Jan 12
|
Amicus (FOLD) Stock Rises More Than 25% in 3 Months: Here's Why
|
|
Jan 12
|
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference
|
|
Jan 11
|
Aclaris (ACRS) Down 21% on Mixed Results From Eczema Study
|
|
Jan 10
|
Why Sarepta's (SRPT) Stock Price Moved Up 17% on Tuesday
|
|
Jan 9
|
Moderna (MRNA) Issues 2023 Preliminary Results, Stock Up 4%
|
|
Jan 2
|
MeiraGTx (MGTX) Stock Surges 35% in a Month: Here's Why
|
|
Dec 21
|
CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 6
|
Pfizer (PFE), Arvinas Post Upbeat Data From Breast Cancer Study
|
|
Dec 5
|
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
|
|
Dec 5
|
CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline
|
|
Dec 5
|
Vanda (VNDA) Rises as FDA Accepts NDA for Gastroparesis Drug
|
|
Dec 1
|
AstraZeneca (AZN) to Discontinue Two Studies on Lokelma
|